Dataset from An Observer-blind Study to Rank Different Formulations of GSK Biologicals' Investigational RSV Vaccine (GSK3003891A) Administered to Healthy Women

The purpose of this study is to rank different RSV vaccine dosages of antigen (or formulations) based on safety/reactogenicity and immune response data. The formulations eliciting strong immune responses while maintaining an acceptable safety profile will be considered for further evaluation, including in studies vaccinating pregnant women.

本研究旨在基于安全性与反应原性（safety/reactogenicity）及免疫应答数据，对不同抗原剂量的呼吸道合胞病毒（Respiratory Syncytial Virus，RSV）疫苗制剂（或配方）进行排序。可诱导强效免疫应答且维持可接受安全性概况的制剂，将被纳入进一步评估范畴，其中包括针对孕妇的接种研究。